Different testosterone esters are often blended into one injectable preparation. In some cases up to seven esters are used, but the most popular formulation is that of Sustanon 250 where four esters are mixed together. This is done to take advantage of the faster acting esters while still only requiring weekly or bi-weekly injections. It is often believed to be a superior form of testosterone, but in reality it’s nothing more than just testosterone. One drawback of testosterone blends are that they incorporate esters with long carbon chains and those chains occupy allot of molecular weight, so the actual dosage of hormone is less than one would obtain from shorter esters like propionate. Testosterone blends are most useful during bulking phases where frequent injections are not possible.
It is very common for bodybuilders to use veterinary steroids for a precontest cycle. Since they are typically assimilated quickly, they do the best work in the shortest amount of time, and are generally out of the system relatively fast in comparison to other ‘roids. And, believe it or not, usually people see fewer side effects when using vet products than when using human ones. Why take anything else? Maybe not ‘why take anything else’, but why not include veterinary steroids, in one form or another, in every cycle? In my mind, veterinary drugs should really be everyone’s choice for extreme condition and definition. They combine well with androgens and other anabolics as well as any drug in the human realm of anabolic steroids. The only problem, these days anyway, is availability. You can find them in Mexico, but you risk fakes, counterfeits, lower quality, or lower dose per ml. You also, of course, face the possibility that you’ll be stopped.
Given the focus on practice-relevant questions in community and practice settings, collaborations between academic researchers and clinical or community practice partners or networks are expected. When possible, studies should capitalize on existing infrastructure (., practice-based research networks such as the NIMH-sponsored Mental Health Research Network (MHRN), electronic medical records, administrative data bases, patient registries, institutions with Clinical and Translational Science Awards ) to increase the efficiency of participant recruitment (., more rapid identification and enrollment) and to facilitate the collection of moderator data (., clinical characteristics, biomarkers), longer-term follow-up data, and broader, stakeholder-relevant outcomes (., mental health and general health care utilization, value and efficiency of intervention approaches).